N-of-1: peptides
An N-of-1 trial (or single-subject design) is a personalised clinical trial where a single patient acts as their own study population. Instead of testing a drug on a large group of people, an individual receives sequential, randomised treatments or placebos over time to determine the optimal care. N-of-1 trials are a core tool in precision medicine to evaluate customised and off-label therapies when a traditional large-scale clinical trial isn’t possible, especially in ultra-rare diseases or chronic conditions. ...